Business Wire (press release) Global Market Report of Candesartan cilexetil (CAS 145040-37-5) aims at providing comprehensive data on Candesartan cilexetil globally and regionally (Europe, Asia, North America, Latin America etc.). It captures Candesartan cilexetil market trends ... and more »
FiercePharma Manufacturing According to four notices in the most recent FDA Enforcement Report, Apotex is recalling 65,442 bottles of candesartan cilexetil made at the company's plant in Bangalore after testing found they contained excessive levels of impurities. The FDA banned ...
Toronto Star Health Canada said at the time that the company refused. The Star has also learned from new FDA records that Apotex recently recalled more than 60,000 bottles of blood pressure tablets — a medication called candesartan cilexetil — because of impurities. and more »
